The intent of the present study was to evaluate the effect of chromium (Cr) as chromium propionate on growth performance, organ index, immune response, intestinal morphology and nutrient transporter gene expression in broilers. One-day-old broiler chicks (n = 756) were divided into six experimental groups of 126 chicks; each group was further divided into 7 replicates (18 chicks/replicate). All birds were offered corn-soybean diets supplemented with Cr at 0, 0.10, 0.15, 0.20, 0.25 or 0.30 mg/kg. Dietary inclusion of Cr at various levels yielded significantly better growth performance and organ index in birds. Similarly, antibody titre against Newcastle disease and avian influenza H5 at various ages was found to be significantly higher in birds that received 0.15 mg/kg Cr in the diet. Significant results with respect to villus height (VH), crypt depth (CD) and VH:CD were observed in all groups that received Cr in the diet compared to control. Moreover, it was observed that different levels of Cr supplementation of the diet also increased the expression of the nutrient transporter genes SGLT1, GLUT2, rBAT and CAT1 in broilers. The findings of the present study suggest that dietary inclusion of Cr at various levels may have beneficial effects on growth performance, immunity, intestinal morphology and nutrient transporter gene expression in broilers. Supplementation of the diet with Cr at a level of 0.15 mg/kg could yield better performance in broiler production.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scitotenv.2019.135869DOI Listing

Publication Analysis

Top Keywords

growth performance
16
nutrient transporter
16
dietary inclusion
12
transporter gene
12
gene expression
12
expression broilers
12
chromium propionate
8
propionate growth
8
immune response
8
performance organ
8

Similar Publications

Background: HER2-targeted therapies have revolutionized the treatment of HER2-positive breast cancer patients, leading to significant improvements in tumor response rates and survival. However, resistance and incomplete response remain considerable challenges. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition is a novel therapeutic strategy for the management of dyslipidemia by enhancing the clearance of low-density lipoprotein cholesterol receptors, however recent evidence also shows links between PCSK9 and cancer cells.

View Article and Find Full Text PDF

Background: Vibrio parahaemolyticus is a marine bacterium causing seafood-associated gastrointestinal illness in humans and acute hepatopancreatic necrosis disease (AHPND) in shrimp. Bacteriophages have emerged as promising biocontrol agents against V. parahaemolyticus.

View Article and Find Full Text PDF

Key performance indicators in emergency department simulation: a scoping review.

Scand J Trauma Resusc Emerg Med

January 2025

Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.

Background: One way to measure emergency department (ED) performance is using key performance indicators (KPIs). Thus, identifying reliable KPIs can be critical in appraising ED performance. This study aims to introduce and classify the KPIs related to ED in simulations through the Balanced Scorecard (BSC) framework.

View Article and Find Full Text PDF

Low-exhaustion peripheral circulating γδ T cells serve as a biomarker for predicting the clinical benefit rate of non-small cell lung cancer (NSCLC) patients to chemotherapy or targeted therapy: a single-center retrospective study.

BMC Cancer

January 2025

Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People's Hospital Affiliated with Jinan University, Jinan University, Zhuhai, China.

Background: Multiple studies have demonstrated that the abundance and functionality of γδ T cells are favorable prognostic indicators for prolonged survival in cancer patients. However, the association between the immunophenotype of circulating γδ T cells and the therapeutic response in NSCLC patients undergoing chemotherapy or targeted therapy remains unclear.

Methods: Patients with EGFR wild-type (EGFR-WT) or mutant (EGFR-Mut) non-small cell lung cancer (NSCLC), diagnosed between January 2020 and January 2024, were included in this study.

View Article and Find Full Text PDF

Background: Coccidia are among the primary pathogens causing diarrhea and even fatalities in lambs. With the increasing use of chemical drugs to treat coccidiosis, the problem of drug resistance is becoming more and more threatening. Therefore, there is an urgent need to identify novel alternative drugs for the treatment of the lamb coccidia.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!